APC and adenoma: Furthermore, mTORC1 inhibitors reduce adenoma size and number, as well as mortality, in Apc mutant mice, demonstrating the importance of mTORC1 activation for tumorigenesis resulting from Apc mutation (Fujishita et al., 2008; Koehl et al., 2010; Metcalfe et al., 2010).